{"podcast":{"title":"The Readout Loud","slug":"the-readout-loud-1134305","podcast_index_feed_id":1134305,"rss_url":"https://feeds.megaphone.fm/thereadoutloud","website_url":"https://soundcloud.com/readout-loud","image_url":"https://megaphone.imgix.net/podcasts/2700b5c2-6d26-11ee-87eb-1f9099431c15/image/517bb4949d560305bb39448edbb32d7a.jpg?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress","author":"STAT","episode_count":414,"summary":"STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.","last_synced_at":"2026-07-17T08:20:19.054206+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305"},"episode":{"title":"396: A new trick for old science, and biotech VCs' scrambled playbook","slug":"396-a-new-trick-for-old-science-and-biotech-vcs-scrambled-playbook","published_at":"2026-04-09T18:41:00+00:00","page_url":"https://stenobird.com/podcast/the-readout-loud-1134305/396-a-new-trick-for-old-science-and-biotech-vcs-scrambled-playbook","show_page_url":"https://stenobird.com/podcast/the-readout-loud-1134305","url":"https://traffic.megaphone.fm/TTSAA5523666345.mp3?updated=1775766569","audio_url":"https://traffic.megaphone.fm/TTSAA5523666345.mp3?updated=1775766569","summary":"Why is old exon science getting new traction? What’s unsettling biotech VCs? And who will be the next CEO of PhRMA? Adam is out, so Elaine and Allison dive into the latest news, including how China and artificial intelligence are straining biotech VC firms, in addition to more M&A. They also discuss how a cancelled Food and Drug Administration meeting led to a biotech’s demise. Plus, there’s new hope for an old theory on treating Duchenne muscular dystrophy. STAT reporter Jason Mast details the clinical testing underway.","meta_description":"Why is old exon science getting new traction? What’s unsettling biotech VCs? And who will be the next CEO of PhRMA? Adam is out, so Elaine and Allison div…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1932,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/396-a-new-trick-for-old-science-and-biotech-vcs-scrambled-playbook/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-readout-loud-1134305/396-a-new-trick-for-old-science-and-biotech-vcs-scrambled-playbook.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}